Urteste (WAR:URT) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:URT Urteste SA WAR:URT
33 GF Score
Price zł43.10
GF Value zł284.41
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Urteste Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Urteste's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

WAR:URT vs VRTX, REGN, RVMD: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Urteste's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Urteste Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Urteste's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Urteste's Margin of Safety % (DCF Earnings Based) falls into.


WAR:URT
33GF Score
Urteste SA WAR:URT
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Urteste (WAR:URT) Overvalued in 2026?

Based on GuruFocus' analysis, Urteste stock appears to be undervalued. The current stock price of zł43.10 is trading 84.8% below its estimated GF Value™ of zł284.41. GuruFocus considers Urteste to be Possible Value Trap.

Key valuation signals for WAR:URT:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: zł284.41 vs. price of zł43.10 (84.8% below fair value)
  • GF Score™: 33/100 with 1 warning sign

No single metric tells the full story. See the WAR:URT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Urteste Business Description

Address ul. Starodworska 1, Gdansk, POL, 80-137
Urteste SA specialises in the development of technology allowing the detection of cancers at the early stages of their development. The companies technology helps detect cancers by measuring the activity of the enzymes in urine. Urteste develops diagnostic tests for more than ten common cancers.
33GF Score

Get the complete analysis for WAR:URT

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł43.10
Price
zł284.41
GF Value